Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Expenses:
Consulting (Note 13)	$ 93,250	$ 148,500
Research and development (Note 10)	6,926	95,884
Selling, general and administrative (Notes 9 and 13)	223,545	274,498
Share-based compensation (Notes 7 and 13)	5,969	84,034
Loss from operations	(329,690)	(602,916)
Interest income	2,330	11,704
Net loss	(327,360)	(591,212)
Other comprehensive income
Currency translation differences	1,686	1,993
Total comprehensive loss	$ (325,674)	$ (589,219)
Net loss per share – basic and diluted (in dollars per share)	$ (0)	$ (0.01)
Weighted average number of common shares outstanding – basic and diluted (in shares)	91,422,569	91,422,569